Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dagmar Schaub

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The Journal of Infection|February 4, 2023
Pretomanid-resistant tuberculosisNiklas Koehler, Sönke Andres, Matthias Merker, et al.
Pathogens & Immunity|February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture ConversionMaja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
The European Respiratory Journal|February 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic modelJan Heyckendorf, Sebastian Marwitz, Maja Reimann, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The Journal of Infection|February 4, 2023
Pretomanid-resistant tuberculosisNiklas Koehler, Sönke Andres, Matthias Merker, et al.
Pathogens & Immunity|February 6, 2025
The TB27 Transcriptomic Model for Predicting <i>Mycobacterium tuberculosis</i> Culture ConversionMaja Reimann, Korkut Avsar, Andrew R DiNardo, et al.
The European Respiratory Journal|February 12, 2021
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic modelJan Heyckendorf, Sebastian Marwitz, Maja Reimann, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 2